These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30909512)

  • 1. Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis.
    Kaçmaz E; Heidsma CM; Besselink MGH; Dreijerink KMA; Klümpen HJ; Nieveen van Dijkum EJM; Engelsman AF
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30909512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET).
    Xue M; Shafie A; Qaiser T; Rajpoot NM; Kaltsas G; James S; Gopalakrishnan K; Fisk A; Dimitriadis GK; Grammatopoulos DK; Rabbani N; Thornalley PJ; Weickert MO
    Oncotarget; 2017 Sep; 8(44):76961-76973. PubMed ID: 29100361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis.
    Almond LM; Hodson J; Ford SJ; Gourevitch D; Roberts KJ; Shah T; Isaac J; Desai A
    Eur J Surg Oncol; 2017 Oct; 43(10):1808-1815. PubMed ID: 28583792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Patterns and Survival among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours in Sweden - a Population-based Register-linkage and Medical Chart Review Study.
    Lesén E; Granfeldt D; Berthon A; Dinet J; Houchard A; Myrenfors P; Björstad Å; Björholt I; Elf AK; Johanson V
    J Cancer; 2019; 10(27):6876-6887. PubMed ID: 31839822
    [No Abstract]   [Full Text] [Related]  

  • 6. Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
    Mujica-Mota R; Varley-Campbell J; Tikhonova I; Cooper C; Griffin E; Haasova M; Peters J; Lucherini S; Talens-Bou J; Long L; Sherriff D; Napier M; Ramage J; Hoyle M
    Health Technol Assess; 2018 Sep; 22(49):1-326. PubMed ID: 30209002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Galleberg RB; Knigge U; Tiensuu Janson E; Vestermark LW; Haugvik SP; Ladekarl M; Langer SW; Grønbæk H; Österlund P; Hjortland GO; Assmus J; Tang L; Perren A; Sorbye H
    Eur J Surg Oncol; 2017 Sep; 43(9):1682-1689. PubMed ID: 28522174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment and survival in patients with liver metastases from neuroendocrine tumors: a meta-analysis of observational studies.
    Bacchetti S; Bertozzi S; Londero AP; Uzzau A; Pasqual EM
    Int J Hepatol; 2013; 2013():235040. PubMed ID: 23509630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance.
    Daskalakis K; Tsoli M; Srirajaskanthan R; Chatzellis E; Alexandraki K; Angelousi A; Pizanias M; Randeva H; Kaltsas G; Weickert MO
    Neuroendocrinology; 2019; 108(4):308-316. PubMed ID: 30673674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Tumor Site Affects Survival in Patients with Gastroenteropancreatic and Neuroendocrine Liver Metastases.
    Tierney JF; Poirier J; Chivukula S; Pappas SG; Hertl M; Schadde E; Keutgen X
    Int J Endocrinol; 2019; 2019():9871319. PubMed ID: 30992703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
    Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
    HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours.
    Clement DSVM; Leerdam MEV; de Jong S; Weickert MO; Ramage JK; Tesselaar MET; Srirajaskanthan R
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-to-liver ratio determined by [
    Kim YI; Yoo C; Oh SJ; Lee SJ; Kang J; Hwang HS; Hong SM; Ryoo BY; Ryu JS
    EJNMMI Res; 2020 Jun; 10(1):63. PubMed ID: 32542576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies.
    Bacchetti S; Pasqual EM; Bertozzi S; Londero AP; Risaliti A
    Gland Surg; 2014 Nov; 3(4):243-51. PubMed ID: 25493256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?
    Lamarca A; Elliott E; Barriuso J; Backen A; McNamara MG; Hubner R; Valle JW
    Cancer Treat Rev; 2016 Mar; 44():26-41. PubMed ID: 26855376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Primary Tumor Resection in Patients With Pancreatic Neuroendocrine Tumors With Liver Metastases.
    Mou Y; Wang ZY; Tan CL; Chen YH; Liu XB; Ke NW
    Front Oncol; 2022; 12():838103. PubMed ID: 35350567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher IL-6 peri-tumoural expression is associated with gastro-intestinal neuroendocrine tumour progression.
    Pereira SS; Pereira R; Santos AP; Costa MM; Morais T; Sampaio P; Machado B; Afonso LP; Henrique R; Monteiro MP
    Pathology; 2019 Oct; 51(6):593-599. PubMed ID: 31466863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
    Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
    Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.